Please assess the completion status of the following clinical trial:

Trial Title: Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Class III or IV heart failure for at least 3 months~* Left ventricular ejection fraction less than or equal to 40%~* Currently being treated for heart failure with standard therapies for at least one month~Exclusion Criteria:~* Women who are pregnant or breastfeeding~* Inability to take oral medications~* Uncontrolled hypertension, bradyarrhythmias or tachyarrhythmias~* Hypertrophic obstructive cardiomyopathy~* Severe obstructive pulmonary disease~* Significant renal impairment~* Significant uncorrected valvular or congenital heart disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).